Everolimus

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Everolimus and local guidelines before prescribing.

mTOR inhibitor

Mechanism

mTOR inhibitor.

Uses

Transplant rejection prophylaxis, renal cell carcinoma, breast cancer, tuberous sclerosis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Stomatitis, infections, hyperlipidaemia, pneumonitis, impaired wound healing.

Interactions

CYP3A4 and P-gp inhibitors and inducers alter levels.

Contraindications and cautions

Active infection

Monitoring

Levels, lipids, glucose, proteinuria

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Reduce dose in hepatic impairment

Overdose and reversal

Supportive

Special advice

Trough levels in transplantation; dental care for stomatitis.

More from the textbook: uses, cautions and other points
Where it is discussed in the book